Sfoglia per Autore
Liposomal daunorubicin (DAUNOXOME) for treatment of relapsed meningeal acute myeloid leukemia.
2001-01-01 Piccaluga, Pp; Visani, G; Isidori, A; Malagola, Michele; Pileri, Sa; Baccarani, M; Tura, S.
Combined action of PSC 833 (Valspodar), a novel MDR reversing agent, with mitoxantrone, etoposide and cytarabine in poor-prognosis acute myeloid leukemia
2001-01-01 Visani, G; Milligan, D; Leoni, F; Chang, J; Kelsey, S; Marcus, R; Powles, R; Schey, S; Covelli, A; Isidori, A; Litchman, M; Piccaluga, Pp; Mayer, H; Malagola, Michele; Pfister, C.
Real-time quantification of minimal residual disease in inv(16) positive acute myeloid leukemia may indicate risk for clinical relapse and may identify patients in a curable state.
2002-01-01 Martinelli, G; Buonamici, S; Ottaviani, E; Testoni, N; Montefusco, V; Visani, G; Bonifazi, F; Amabile, M; Terragna, C; Ruggeri, D; Piccaluga, Pp; Isidori, A; Malagola, Michele; Baccarani, M; Tura, S.
Association of 3q26 syndrome with different RPN1/EVI1 fusion transcripts in acute myeloblastic leukemia patients.
2002-01-01 Martinelli, G; Ottaviani, E; Isidori, A; Malagola, Michele; Buonamici, S; Testoni, N; Visnai, G; Piccaluga, P; Rondoni, M; Tura, S; Baccarani, M.
Chronic myeloid leukemia patients with complete karyotypic response to STI-571 (GLIVEC) therapy show rapid reduction of bcr-abl trancripts.
2002-01-01 Giannini, B; Martinelli, G; Rosti G., Amabile M; Trabacchi, E; Testoni, N; Buonamici, S; Ottaviani, E; Soverini, S; Bassi, S; Pane, F; Izzo, B; Saglio, G; Alberti, D; Baccarani, M; Isidori, A; Malagola, Michele; Piccaluga, Pp; Rondoni, M. on behalf of the ICSG C. M. L.
Efficacy of imatinib mesylate (STI 571) in conjunction with -interpheron: long term quantitative molecular remission in relapsed positive acute lymphoblastic leukemia.
2002-01-01 Visani, G; Isidori, A; Alberti, D; Malagola, Michele; Piccaluga, Pp; Martinelli, G; Amabile, M; Tura, S; Baccarani, M.
Antiangiogenic activity of thalidomide in myelofibrosis with myeloid metaplasia and myelodisplastic syndromes. Analysis of microvessels density and angiogenesis surrogate markers.
2002-01-01 Piccaluga, Pp; Visani, G; Pileri, Sa; Martinelli, G; Finelli, C; Ascani, S; Grafone, T; Isidori, A; Malagola, Michele; El cheick, J; Rondoni, M; Baccarani, M; Tura, S.
Real time quantification of minimal residual disease in inv(16)-positive acute myeloid leukemia may indicate arisk for clinical relapse and may identify patients in curable state
2002-01-01 Buonamici, S; Ottaviani, E; Testoni, N; Montefusco, V; Visani, G; Bonifazi, F; Amabile, M; Terragna, C; Ruggeri, D; Piccaluga, Pp; Isidori, A; Malagola, Michele; Baccarani, M; Tura, S; Martinelli, G.
Assoication of 3q21 syndrome with different RPN1/EVI1 fusion transcript in AML patients.
2002-01-01 Martinelli, G; Ottaviani, E; Isidori, A; Malagola, Michele; Buonamici, S; Testoni, N; Visani, G; Piccaluga, Pp; Rondoni, M; Tura, S; Baccarani, M.
Antiangiogenic activity and clinical efficacy of thalidomide in myelodiysplastic syndromes: report of two cases.
2002-01-01 Picaluga, Pp; Finelli, C; Visani, G; Martinelli, G; Grafone, T; Ascani, S; Isidori, A; Malagola, Michele; El Cheich, J; Pileri, Sa; Baccarani, M; Tura, S.
Liposomal daunorubicin (DaunoXome) for the treatment of relapsed meningeal acute myeloid leukemia.
2002-01-01 Piccaluga, Pp; Visani, G; Martinelli, G; Isidori, A; Malagola, Michele; Rondoni, M; Baccarani, M; Tura, S.
Gentuzumab Ozogamycin (Mylotarg) for the treatment of relapsed/refractory acute myeloid leukemia. A single Centre experience.
2002-01-01 Piccaluga, Pp; Martinelli, G; Rondoni, M; Isidori, A; Malagola, Michele; Visani, G; Tura, S; Baccarani, M.
Efficacy of imatinib mesylate (STI 571) in conjunction with alpha-interpheron: long term quantitative molecular remission in relapsed positive acute lymphoblastic leukemia.
2002-01-01 Visani, G; Isidori, A; Malagola, Michele; Alberti, D; Capdeville, R; Martinelli, G; Piccaluga, Pp; Amabile, M; Guiducci, B; Tura, S; Baccarani, M.
Clinical efficacy and antiangiogenic activity of thalidomide in myelofibrosis with myeloid metaplasia. A pilot study.
2002-01-01 Piccaluga, Pp; Visani, G; Pileri, Sa; Ascani, S; Grafone, T; Isidori, A; Malagola, Michele; Finelli, C; Martinelli, G; Ricci, P; Baccarani, M; Tura, S.
Two more inv(16) acute myeloid leukemia cases with infrequent CBFalpha-MYH11 fusion transcript: clinical and molecular findings.
2002-01-01 Martinelli, G; Ottaviani, E; Buonamici, S; Isidori, A; Malagola, Michele; Piccaluga, Pp; Baccarani, M.
Rapid detection of Flt3-ITD in acute myeloid leukemia patients by DF-HPLC
2002-01-01 Martinelli, G; Bianchini, M; Giannini, B; Grafone, T; Ottaviani, E; Amabile, M; Terragna, C; Soverini, S; Piccaluga, Pp; Isidori, A; Malagola, Michele; Rondoni, M; Buonamici, S; Baccarani, M.
Efficacy and feasibility of Gemtuzumab Ozogamicin plus cytarabine in the treatment of poor risk acute myeloid leukemia.
2003-01-01 Piccaluga, Pp; Martinelli, G; Rondoni, M; Bonini, A; Bosi, C; El Cheick, J; Finelli, C; Gaitani, S; Isidori, A; Gugliotta, L; Luppi, M; Malagola, Michele; Morselli, M; Pileri, S; Russo, Domenico; Sparaventi, D; Vigna, E; Visani, G; Baccarani, M.
Allogeneic Stem Cell Transplantation (SCT) for myelodysplastic synromes (MDS) and secondary acute myeloid leukemia. Retrospective study of 32 patients from a single institution.
2003-01-01 Finelli, C; Bonifazi, F; El Cheick, J; Bandini, G; Arpianti, M; Falcioni, S; Stanzani, M; Vigna, E; Malagola, Michele; Rondoni, M; Bosi, C; Piccaluga, Pp; Gaitnai, S; Martinelli, G; Testoni, N; Baccarani, M.
Complete cytogenetic remission in acute myeloid leukemia with granulocyte colony stimulating factor without chemotherapy. A case report.
2003-01-01 Vigna, E; Piccaluga, Pp; Martinelli, G; Malagola, Michele; Rondoni, M; Bosi, C; Gaitani, S; Testoni, N; Luatti, S; Ottaviani, E; Bianchini, M; Giannini, B; Grafone, T; Finelli, C; El Cheick, J; Dizdari, A; Visani, G; Baccarani, M.
Imatinib seems to be inefective in patients with systemic mastocytosis carrying the Asp816Val c-kit mutation.
2003-01-01 Rondoni, M; Soverini, S; Malagola, Michele; Ottavini, E; Piccaluga, Pp; Bosi, C; Gentili, S; Gozzatti, A; Lauria, F; Bertoldero, G; Minotto, C; Vinante, O; Vivaldi, P; Bertieri, R; Gitani, S; Martinelli, G; Baccarani, M.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Liposomal daunorubicin (DAUNOXOME) for treatment of relapsed meningeal acute myeloid leukemia. | 1-gen-2001 | Piccaluga, Pp; Visani, G; Isidori, A; Malagola, Michele; Pileri, Sa; Baccarani, M; Tura, S. | |
| Combined action of PSC 833 (Valspodar), a novel MDR reversing agent, with mitoxantrone, etoposide and cytarabine in poor-prognosis acute myeloid leukemia | 1-gen-2001 | Visani, G; Milligan, D; Leoni, F; Chang, J; Kelsey, S; Marcus, R; Powles, R; Schey, S; Covelli, A; Isidori, A; Litchman, M; Piccaluga, Pp; Mayer, H; Malagola, Michele; Pfister, C. | |
| Real-time quantification of minimal residual disease in inv(16) positive acute myeloid leukemia may indicate risk for clinical relapse and may identify patients in a curable state. | 1-gen-2002 | Martinelli, G; Buonamici, S; Ottaviani, E; Testoni, N; Montefusco, V; Visani, G; Bonifazi, F; Amabile, M; Terragna, C; Ruggeri, D; Piccaluga, Pp; Isidori, A; Malagola, Michele; Baccarani, M; Tura, S. | |
| Association of 3q26 syndrome with different RPN1/EVI1 fusion transcripts in acute myeloblastic leukemia patients. | 1-gen-2002 | Martinelli, G; Ottaviani, E; Isidori, A; Malagola, Michele; Buonamici, S; Testoni, N; Visnai, G; Piccaluga, P; Rondoni, M; Tura, S; Baccarani, M. | |
| Chronic myeloid leukemia patients with complete karyotypic response to STI-571 (GLIVEC) therapy show rapid reduction of bcr-abl trancripts. | 1-gen-2002 | Giannini, B; Martinelli, G; Rosti G., Amabile M; Trabacchi, E; Testoni, N; Buonamici, S; Ottaviani, E; Soverini, S; Bassi, S; Pane, F; Izzo, B; Saglio, G; Alberti, D; Baccarani, M; Isidori, A; Malagola, Michele; Piccaluga, Pp; Rondoni, M. on behalf of the ICSG C. M. L. | |
| Efficacy of imatinib mesylate (STI 571) in conjunction with -interpheron: long term quantitative molecular remission in relapsed positive acute lymphoblastic leukemia. | 1-gen-2002 | Visani, G; Isidori, A; Alberti, D; Malagola, Michele; Piccaluga, Pp; Martinelli, G; Amabile, M; Tura, S; Baccarani, M. | |
| Antiangiogenic activity of thalidomide in myelofibrosis with myeloid metaplasia and myelodisplastic syndromes. Analysis of microvessels density and angiogenesis surrogate markers. | 1-gen-2002 | Piccaluga, Pp; Visani, G; Pileri, Sa; Martinelli, G; Finelli, C; Ascani, S; Grafone, T; Isidori, A; Malagola, Michele; El cheick, J; Rondoni, M; Baccarani, M; Tura, S. | |
| Real time quantification of minimal residual disease in inv(16)-positive acute myeloid leukemia may indicate arisk for clinical relapse and may identify patients in curable state | 1-gen-2002 | Buonamici, S; Ottaviani, E; Testoni, N; Montefusco, V; Visani, G; Bonifazi, F; Amabile, M; Terragna, C; Ruggeri, D; Piccaluga, Pp; Isidori, A; Malagola, Michele; Baccarani, M; Tura, S; Martinelli, G. | |
| Assoication of 3q21 syndrome with different RPN1/EVI1 fusion transcript in AML patients. | 1-gen-2002 | Martinelli, G; Ottaviani, E; Isidori, A; Malagola, Michele; Buonamici, S; Testoni, N; Visani, G; Piccaluga, Pp; Rondoni, M; Tura, S; Baccarani, M. | |
| Antiangiogenic activity and clinical efficacy of thalidomide in myelodiysplastic syndromes: report of two cases. | 1-gen-2002 | Picaluga, Pp; Finelli, C; Visani, G; Martinelli, G; Grafone, T; Ascani, S; Isidori, A; Malagola, Michele; El Cheich, J; Pileri, Sa; Baccarani, M; Tura, S. | |
| Liposomal daunorubicin (DaunoXome) for the treatment of relapsed meningeal acute myeloid leukemia. | 1-gen-2002 | Piccaluga, Pp; Visani, G; Martinelli, G; Isidori, A; Malagola, Michele; Rondoni, M; Baccarani, M; Tura, S. | |
| Gentuzumab Ozogamycin (Mylotarg) for the treatment of relapsed/refractory acute myeloid leukemia. A single Centre experience. | 1-gen-2002 | Piccaluga, Pp; Martinelli, G; Rondoni, M; Isidori, A; Malagola, Michele; Visani, G; Tura, S; Baccarani, M. | |
| Efficacy of imatinib mesylate (STI 571) in conjunction with alpha-interpheron: long term quantitative molecular remission in relapsed positive acute lymphoblastic leukemia. | 1-gen-2002 | Visani, G; Isidori, A; Malagola, Michele; Alberti, D; Capdeville, R; Martinelli, G; Piccaluga, Pp; Amabile, M; Guiducci, B; Tura, S; Baccarani, M. | |
| Clinical efficacy and antiangiogenic activity of thalidomide in myelofibrosis with myeloid metaplasia. A pilot study. | 1-gen-2002 | Piccaluga, Pp; Visani, G; Pileri, Sa; Ascani, S; Grafone, T; Isidori, A; Malagola, Michele; Finelli, C; Martinelli, G; Ricci, P; Baccarani, M; Tura, S. | |
| Two more inv(16) acute myeloid leukemia cases with infrequent CBFalpha-MYH11 fusion transcript: clinical and molecular findings. | 1-gen-2002 | Martinelli, G; Ottaviani, E; Buonamici, S; Isidori, A; Malagola, Michele; Piccaluga, Pp; Baccarani, M. | |
| Rapid detection of Flt3-ITD in acute myeloid leukemia patients by DF-HPLC | 1-gen-2002 | Martinelli, G; Bianchini, M; Giannini, B; Grafone, T; Ottaviani, E; Amabile, M; Terragna, C; Soverini, S; Piccaluga, Pp; Isidori, A; Malagola, Michele; Rondoni, M; Buonamici, S; Baccarani, M. | |
| Efficacy and feasibility of Gemtuzumab Ozogamicin plus cytarabine in the treatment of poor risk acute myeloid leukemia. | 1-gen-2003 | Piccaluga, Pp; Martinelli, G; Rondoni, M; Bonini, A; Bosi, C; El Cheick, J; Finelli, C; Gaitani, S; Isidori, A; Gugliotta, L; Luppi, M; Malagola, Michele; Morselli, M; Pileri, S; Russo, Domenico; Sparaventi, D; Vigna, E; Visani, G; Baccarani, M. | |
| Allogeneic Stem Cell Transplantation (SCT) for myelodysplastic synromes (MDS) and secondary acute myeloid leukemia. Retrospective study of 32 patients from a single institution. | 1-gen-2003 | Finelli, C; Bonifazi, F; El Cheick, J; Bandini, G; Arpianti, M; Falcioni, S; Stanzani, M; Vigna, E; Malagola, Michele; Rondoni, M; Bosi, C; Piccaluga, Pp; Gaitnai, S; Martinelli, G; Testoni, N; Baccarani, M. | |
| Complete cytogenetic remission in acute myeloid leukemia with granulocyte colony stimulating factor without chemotherapy. A case report. | 1-gen-2003 | Vigna, E; Piccaluga, Pp; Martinelli, G; Malagola, Michele; Rondoni, M; Bosi, C; Gaitani, S; Testoni, N; Luatti, S; Ottaviani, E; Bianchini, M; Giannini, B; Grafone, T; Finelli, C; El Cheick, J; Dizdari, A; Visani, G; Baccarani, M. | |
| Imatinib seems to be inefective in patients with systemic mastocytosis carrying the Asp816Val c-kit mutation. | 1-gen-2003 | Rondoni, M; Soverini, S; Malagola, Michele; Ottavini, E; Piccaluga, Pp; Bosi, C; Gentili, S; Gozzatti, A; Lauria, F; Bertoldero, G; Minotto, C; Vinante, O; Vivaldi, P; Bertieri, R; Gitani, S; Martinelli, G; Baccarani, M. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile